scispace - formally typeset
M

Margaret F. Lippincott

Researcher at Harvard University

Publications -  36
Citations -  1621

Margaret F. Lippincott is an academic researcher from Harvard University. The author has contributed to research in topics: Kisspeptin & Hypogonadotropic hypogonadism. The author has an hindex of 17, co-authored 33 publications receiving 1325 citations. Previous affiliations of Margaret F. Lippincott include National Institutes of Health & Brigham and Women's Hospital.

Papers
More filters
Journal ArticleDOI

Primary care physician time utilization before and after implementation of an electronic health record: a time-motion study

TL;DR: A time-motion study in five primary care clinics found that the EHR did not require more time for physicians during a clinic session, but further studies should assess the E HR's potential impact on non-clinic time.
Journal ArticleDOI

Reversal and relapse of hypogonadotropic hypogonadism: resilience and fragility of the reproductive neuroendocrine system.

TL;DR: Reversal of IHH may be more widespread than previously appreciated and occurs across a broad range of genotypes and phenotypes, and enrichment for mutations affecting neurokinin B signaling in patients who reversed indicates that this signaling pathway for normal pubertal timing is dispensable later in life.
Journal ArticleDOI

Burden Testing of Rare Variants Identified through Exome Sequencing via Publicly Available Control Data

TL;DR: The approach "re-discovered" genes previously implicated in IHH and introduced an approach for highly adaptable variant quality filtering that leads to well-calibrated results, and developed a user-friendly software package for performing gene-based burden testing against public databases.
Journal ArticleDOI

SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome

Natalie D. Shaw, +88 more
- 01 Feb 2017 - 
TL;DR: In this article, the authors found that SMCHD1 mutations cause facioscapulohumeral muscular dystrophy type 2 (FSHD2) via a trans-acting loss-of-function epigenetic mechanism.
Journal ArticleDOI

Primary care physician attitudes towards using a secure web-based portal designed to facilitate electronic communication with patients.

TL;DR: Overall, physicians felt that Patient Gateway's impact on their practices was positive, especially in the areas of refill and referral request management and appointment scheduling, and they would be more enthusiastic about electronic communication with patients if this time were compensated.